BCL2 and idiopathic pulmonary fibrosis: Additionally, senolytic agents such as navitoclax (a Bcl-2 family inhibitor) and flavonoid fisetin clear senescent fibroblasts in both IPF and cutaneous fibrosis models [98,327,328,329].